Korea Information Service

Il Sung Pharm. (003120)

STOCK


	(Unit : %, Times)

Fiscal Year End	2003.12.31	2004.12.31	2005.12.31	2006.12.31	2007. 6.30
Net Income to Total Assets	10.47	11.20	16.15	16.00	6.74
Ordinary Income to Total Assets	15.77	16.72	22.73	22.54	9.54
Operating Profit to Working Capital	15.39	14.20	17.25	22.84	26.49
Net Income to Equity	12.02	12.55	18.63	18.98	8.07
Net Income to Sales	16.75	20.04	36.49	49.03	25.50
Ordinary Income to Sales	25.21	29.92	51.36	69.08	36.12
Operating Income to Sales	22.33	22.86	25.83	26.86	27.51
Total Income to Sales	44.44	45.61	49.45	52.66	52.82
Times Interest earned	6,410.71	18,979.92	12,653.35	1,478.55	590.74
Financial Expenses/Sales	-	-	-	0.05	0.06
Equity to Total Assets	88.10	90.12	84.36	84.22	82.90
Liability to Equity	13.51	10.96	18.54	18.73	20.63
Borrowings & Bonds to Assets	-	-	-	-	-
Current Liabilities to Equity	12.79	10.31	13.36	9.65	5.70
Fixed Assets to Equity & L/T Liabilities	37.17	19.45	70.04	80.63	85.36
Fixed Ratio	37.44	19.58	73.66	87.95	98.10
Current Ratio	594.69	886.53	335.82	318.85	395.35
Quick Ratio	478.88	789.14	282.26	253.54	294.23
Debt Coverage Ratio	488,954.55	1,447,294.50	958,383.40	109,718.63	45,447.91
Total C/F to Liabilities	104.39	124.72	48.96	29.36	-
Business Capital Turn over	0.69	0.62	0.67	0.85	0.96
Total Assets Turn over	0.63	0.56	0.44	0.33	0.26
Trade Receivables Turn over	3.11	3.37	3.47	3.24	3.16
Inventories Turn over	4.65	5.15	6.10	5.80	5.27
Trade Payables Turn over	12.11	13.54	15.68	14.23	14.41
Sales Growth	0.89	4.77	7.97	1.82	2.39
Total Asset Growth	12.11	21.87	48.12	31.34	29.92
Equity Growth	14.73	24.67	38.66	31.13	27.88


	(Unit : %)


	(Unit : 100Mn. Won, %)